Citation Impact
Citing Papers
Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2
1997
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.
1993
Visfatin, an Adipocytokine with Proinflammatory and Immunomodulating Properties
2007
Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent
1995
Cytokines in inflammatory bowel disease
2014 Standout
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Ulcerative Colitis
2011 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Correlations of C-reactive Protein Levels and Erythrocyte Sedimentation Rates with Endoscopic Activity Indices in Patients with Ulcerative Colitis
2013
The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease
1999
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
2014 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Discovery and characterization of olokizumab
2014
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Development, cytokine profile and function of human interleukin 17–producing helper T cells
2007 Standout
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Inflammatory Bowel Disease
2009 Standout
The IL-6/sIL-6R complex as a novel target for therapeutic approaches
2007
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
2002
IL-6 as a keystone cytokine in health and disease
2015 Standout
The Key Role of Macrophages in the Immunopathogenesis of Inflammatory Bowel Disease
2000
Involvement of IL-6 in the Pathogenesis of Inflammatory Bowel Disease and Colon Cancer
2005
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
2002 Standout
Adipokines in inflammation and metabolic disease
2011 Standout
Lipocalins as biochemical markers of disease
2000
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells
2007 Standout
Inflammation and Colon Cancer
2010 Standout
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2000 Standout
Clinical Relevance of Serum Interleukin-6 in Crohn's Disease: Single Point Measurements, Therapy Monitoring, and Prediction of Clinical Relapse
1999
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Cardiorenal Syndrome
2008 Standout
Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease
1995
Intestinal mucosal barrier function in health and disease
2009 Standout
Interleukin-6 trans-signaling in inflammatory bowel disease
2006
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
2004 StandoutNature
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Ulcerative colitis
2016 Standout
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#
2007
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
2009 Standout
Eicosanoids and cancer
2010 Standout
Intestinal permeability and the prediction of relapse in Crohn's disease
1993
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
2006
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
2006
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
2006 Standout
ESPEN Guidelines on Enteral Nutrition: Gastroenterology
2006
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
2012
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
2005 Standout
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
The limitations of corticosteroid therapy in Crohn’s disease
2001
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998
2007
Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
1994
Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation
2001
Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease
1993
IL-17 and Th17 Cells
2009 Standout
IL-17 Family Cytokines and the Expanding Diversity of Effector T Cell Lineages
2007 Standout
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Inflammatory Bowel Disease
2010 Standout
Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD)
1995
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis
2000
Budesonide for induction of remission in Crohn's disease
2015
Cytokines in Inflammatory Bowel Disease
1998
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
2006
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
2011 Standout
Works of I. Caesar being referenced
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.
1996
Erstsymptome, extraintestinale Manifestationen und Schwangerschaftsverlauf bei chronisch entzündlichen Darmerkrankungen
1998
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization
2004
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
1992
Focal white-matter lesions in brain of patients with inflammatory bowel disease
1995
Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group.
1995
Mangelzustände und Komplikationen bei chronisch entzündlichen Darmerkrankungen
1998
Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.
1997
Erstsymptome, extraintestinale Manifestationen und Schwangerschaftsverlauf bei chronisch entzündlichen Darmerkrankungen
1998